CoreAge Rx vs RENN Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and RENN Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 73 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make RENN Health a bad call — it's best for readers who want continuing virtual follow-ups and will obtain the medication formulation and full subscription terms before paying. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | RENN Health |
|---|---|---|
| Brief Score | 94/100 (A) | 73/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm formulation and total Advertises $149 starting and $249 ongoing. Introductory term, full payment and branded versus compounded formulation remain unconfirmed. Full price detailsCurrent semaglutide formulation and complete quote unknown; earlier listing: From $149/mo (term not published, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm formulation and total Advertises $199 starting and $299 ongoing. Introductory term, full payment and branded versus compounded formulation remain unconfirmed. Full price detailsCurrent tirzepatide formulation and complete quote unknown; earlier listing: From $199/mo (term not published, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises virtual care in all 50 states; confirm medication-specific clinician and pharmacy eligibility |
| Brand-name access | Not confirmed | Brand or compounded formulation unconfirmed |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
RENN Health: RENN lists $149/$199 headline rates but $249/$299 ongoing program rates on its About page. Introductory terms and medication formulation remain unconfirmed.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.